Matrix metalloproteinase-12 as an endogenous resolution promoting factor following myocardial infarction

Alan J. Mouton, Osvaldo J. Rivera Gonzalez, Amanda R. Kaminski, Edwin T. Moore, Merry L. Lindsey

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Following myocardial infarction (MI), timely resolution of inflammation promotes wound healing and scar formation while limiting excessive tissue damage. Resolution promoting factors (RPFs) are agents that blunt leukocyte trafficking and inflammation, promote necrotic and apoptotic cell clearance, and stimulate scar formation. Previously identified RPFs include mediators derived from lipids (resolvins, lipoxins, protectins, and maresins), proteins (glucocorticoids, annexin A1, galectin 1, and melanocortins), or gases (CO, H 2 S, and NO). Matrix metalloproteinase-12 (MMP-12; macrophage elastase) has shown promising RPF qualities in a variety of disease states. We review here the evidence that MMP-12 may serve as a novel RPF with potential therapeutic efficacy in the setting of MI.

Original languageEnglish (US)
Pages (from-to)252-258
Number of pages7
JournalPharmacological Research
Volume137
DOIs
StatePublished - Nov 2018

Fingerprint

Matrix Metalloproteinase 12
Matrix Metalloproteinases
Cicatrix
CD59 Antigens
Myocardial Infarction
Lipoxins
Galectin 1
Annexin A1
Melanocortins
Inflammation
Pancreatic Elastase
Carbon Monoxide
Wound Healing
Glucocorticoids
Leukocytes
Gases
Macrophages
Proteins
Therapeutics

Keywords

  • Extracellular matrix
  • Fibroblast
  • Inflammation
  • Inflammation resolution
  • Macrophage
  • Neutrophil

ASJC Scopus subject areas

  • Pharmacology

Cite this

Matrix metalloproteinase-12 as an endogenous resolution promoting factor following myocardial infarction. / Mouton, Alan J.; Rivera Gonzalez, Osvaldo J.; Kaminski, Amanda R.; Moore, Edwin T.; Lindsey, Merry L.

In: Pharmacological Research, Vol. 137, 11.2018, p. 252-258.

Research output: Contribution to journalReview article

Mouton, Alan J. ; Rivera Gonzalez, Osvaldo J. ; Kaminski, Amanda R. ; Moore, Edwin T. ; Lindsey, Merry L. / Matrix metalloproteinase-12 as an endogenous resolution promoting factor following myocardial infarction. In: Pharmacological Research. 2018 ; Vol. 137. pp. 252-258.
@article{94ec3c317ecf4b3cac07513df7bb84eb,
title = "Matrix metalloproteinase-12 as an endogenous resolution promoting factor following myocardial infarction",
abstract = "Following myocardial infarction (MI), timely resolution of inflammation promotes wound healing and scar formation while limiting excessive tissue damage. Resolution promoting factors (RPFs) are agents that blunt leukocyte trafficking and inflammation, promote necrotic and apoptotic cell clearance, and stimulate scar formation. Previously identified RPFs include mediators derived from lipids (resolvins, lipoxins, protectins, and maresins), proteins (glucocorticoids, annexin A1, galectin 1, and melanocortins), or gases (CO, H 2 S, and NO). Matrix metalloproteinase-12 (MMP-12; macrophage elastase) has shown promising RPF qualities in a variety of disease states. We review here the evidence that MMP-12 may serve as a novel RPF with potential therapeutic efficacy in the setting of MI.",
keywords = "Extracellular matrix, Fibroblast, Inflammation, Inflammation resolution, Macrophage, Neutrophil",
author = "Mouton, {Alan J.} and {Rivera Gonzalez}, {Osvaldo J.} and Kaminski, {Amanda R.} and Moore, {Edwin T.} and Lindsey, {Merry L.}",
year = "2018",
month = "11",
doi = "10.1016/j.phrs.2018.10.026",
language = "English (US)",
volume = "137",
pages = "252--258",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Matrix metalloproteinase-12 as an endogenous resolution promoting factor following myocardial infarction

AU - Mouton, Alan J.

AU - Rivera Gonzalez, Osvaldo J.

AU - Kaminski, Amanda R.

AU - Moore, Edwin T.

AU - Lindsey, Merry L.

PY - 2018/11

Y1 - 2018/11

N2 - Following myocardial infarction (MI), timely resolution of inflammation promotes wound healing and scar formation while limiting excessive tissue damage. Resolution promoting factors (RPFs) are agents that blunt leukocyte trafficking and inflammation, promote necrotic and apoptotic cell clearance, and stimulate scar formation. Previously identified RPFs include mediators derived from lipids (resolvins, lipoxins, protectins, and maresins), proteins (glucocorticoids, annexin A1, galectin 1, and melanocortins), or gases (CO, H 2 S, and NO). Matrix metalloproteinase-12 (MMP-12; macrophage elastase) has shown promising RPF qualities in a variety of disease states. We review here the evidence that MMP-12 may serve as a novel RPF with potential therapeutic efficacy in the setting of MI.

AB - Following myocardial infarction (MI), timely resolution of inflammation promotes wound healing and scar formation while limiting excessive tissue damage. Resolution promoting factors (RPFs) are agents that blunt leukocyte trafficking and inflammation, promote necrotic and apoptotic cell clearance, and stimulate scar formation. Previously identified RPFs include mediators derived from lipids (resolvins, lipoxins, protectins, and maresins), proteins (glucocorticoids, annexin A1, galectin 1, and melanocortins), or gases (CO, H 2 S, and NO). Matrix metalloproteinase-12 (MMP-12; macrophage elastase) has shown promising RPF qualities in a variety of disease states. We review here the evidence that MMP-12 may serve as a novel RPF with potential therapeutic efficacy in the setting of MI.

KW - Extracellular matrix

KW - Fibroblast

KW - Inflammation

KW - Inflammation resolution

KW - Macrophage

KW - Neutrophil

UR - http://www.scopus.com/inward/record.url?scp=85055735258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055735258&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2018.10.026

DO - 10.1016/j.phrs.2018.10.026

M3 - Review article

C2 - 30394317

AN - SCOPUS:85055735258

VL - 137

SP - 252

EP - 258

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -